1. Home
  2. SAIC vs TERN Comparison

SAIC vs TERN Comparison

Compare SAIC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$95.49

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Terns Pharmaceuticals Inc.

TERN

Terns Pharmaceuticals Inc.

HOLD

Current Price

$52.98

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
TERN
Founded
1969
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.8B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
SAIC
TERN
Price
$95.49
$52.98
Analyst Decision
Hold
Buy
Analyst Count
8
12
Target Price
$110.50
$45.22
AVG Volume (30 Days)
407.8K
5.7M
Earning Date
06-01-2026
05-14-2026
Dividend Yield
1.56%
N/A
EPS Growth
7.39
8.04
EPS
7.70
N/A
Revenue
$7,262,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.65
N/A
P/E Ratio
$12.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.08
$2.82
52 Week High
$124.11
$53.19

Technical Indicators

Market Signals
Indicator
SAIC
TERN
Relative Strength Index (RSI) 49.40 74.51
Support Level $95.21 $52.42
Resistance Level $96.77 $53.19
Average True Range (ATR) 2.82 0.07
MACD 0.06 -0.31
Stochastic Oscillator 45.65 97.30

Price Performance

Historical Comparison
SAIC
TERN

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Share on Social Networks: